Felker, G M <br/><br/>
Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure.  [electronic resource] 

 -  American heart journal  Dec 2001 
 - 932-3 p.  digital 
<br/><br/> Publication Type: Comment; Comparative Study; Editorial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1067/mhj.2001.119611  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--adverse effects<br/>Arrhythmias, Cardiac--chemically induced<br/>Cardiotonic Agents--adverse effects<br/>Clinical Trials as Topic<br/>Cost-Benefit Analysis<br/>Heart Failure--drug therapy<br/>Heart Transplantation<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypotension--chemically induced<br/>Research Design<br/>Treatment Outcome